Abstract PO1-09-09: The journey of HR positive, HER2 negative metastatic breast cancer’s patients: heterogeneities and barriers in Brazilian public health system- a national survey

View Full Paper

Ask AI

Bookmark

Authors

Discussion

National survey reveals disparities in treatment accessibility and supportive care for breast cancer patients in Brazil.

Patients in the SUS face longer wait times for treatments, with median delays of 60 days for surgery and 30 days for chemotherapy.
Oncologists reported significant barriers, such as limited availability of critical endocrine therapies and chemotherapy agents within the public health system.
Survey data gathered from 150 oncologists highlighted differences in the availability of multidisciplinary support between SUS and private care, impacting patient journeys in treatment access and support services. 63% of oncologists in SUS reported palliative care availability, compared to 82% in the private sector, indicating significant service gaps.

Resende et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark